Cargando…
Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease
BACKGROUND: Current guidelines recommend a susceptibility-based regimen for Mycobacterium abscessus subspecies abscessus pulmonary disease (MAB-PD), but the evidence is weak. We aimed to investigate the association between treatment outcomes and in vitro drug susceptibility to injectable antibiotics...
Autores principales: | Park, Youngmok, Park, Yea Eun, Jhun, Byung Woo, Park, Jimyung, Kwak, Nakwon, Jo, Kyung-Wook, Yim, Jae-Joon, Shim, Tae Sun, Kang, Young Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231371/ https://www.ncbi.nlm.nih.gov/pubmed/34189168 http://dx.doi.org/10.1093/ofid/ofab215 |
Ejemplares similares
-
Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease
por: Jo, Kyung-Wook, et al.
Publicado: (2020) -
In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea
por: Park, Sunghoon, et al.
Publicado: (2008) -
Mycobacterium abscessus Complex Infections: A Retrospective Cohort Study
por: Sfeir, Maroun, et al.
Publicado: (2018) -
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
por: Pearson, Jeffrey C, et al.
Publicado: (2020) -
Invasive Mycobacterium abscessus Outbreak at a Pediatric Dental Clinic
por: Singh, Jasjit, et al.
Publicado: (2021)